Innova Captab Limited

Innova Captab Limited (INNOVACAP) financial statements and selected valuation metrics from NSE/BSE exchange filings through 30 June 2026.

HealthcareHealthcarePharmaceuticals & BiotechnologyPharmaceuticals

innovacaptab.com(opens the company website in a new tab)
Ask AI

Key metrics

Price as of 2026-09-03

Stock price
₹1125.40
Market cap
6,441 Cr
Stock P/E
38.7
P/B
5.91
Dividend yield
0.2%

Sign in for full ratios and TTM. Learn about these metrics →

Share price

NSE closing price from historical market data.

Loading price history…

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Sales283 Cr302 Cr263 Cr294 Cr318 Cr316 Cr315 Cr352 Cr380 Cr450 Cr448 Cr471 Cr
Operating expenses (approx.)242 Cr258 Cr225 Cr252 Cr268 Cr270 Cr267 Cr299 Cr329 Cr381 Cr383 Cr398 Cr
EBITDA40 Cr45 Cr38 Cr42 Cr50 Cr47 Cr48 Cr52 Cr52 Cr69 Cr65 Cr73 Cr
OPM %14.3%14.7%14.5%14.3%15.6%14.7%15.2%14.8%13.6%15.4%14.5%15.5%
Other income3 Cr2 Cr6 Cr2 Cr2 Cr4 Cr3 Cr4 Cr4 Cr2 Cr2 Cr2 Cr
Interest9 Cr7 Cr0.81 Cr0.14 Cr0.15 Cr0.17 Cr2 Cr3 Cr5 Cr4 Cr5 Cr4 Cr
Depreciation5 Cr5 Cr3 Cr5 Cr5 Cr5 Cr10 Cr11 Cr11 Cr11 Cr11 Cr12 Cr
Profit before tax30 Cr35 Cr40 Cr39 Cr47 Cr46 Cr39 Cr43 Cr39 Cr56 Cr51 Cr59 Cr
Tax %24.1%28.6%27.4%25.0%25.2%25.0%24.8%27.3%24.4%24.3%24.8%25.2%
Net profit23 Cr25 Cr29 Cr29 Cr35 Cr34 Cr30 Cr31 Cr30 Cr42 Cr38 Cr44 Cr
EPS (₹)₹4.77₹4.39₹5.02₹5.15₹6.12₹5.97₹5.17₹5.42₹5.18₹7.37₹6.65₹7.71

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2024Mar 2025Mar 2026TTM
Sales1,081 Cr1,244 Cr1,630 CrSign in for TTM
Operating expenses (approx.)927 Cr1,058 Cr1,387 CrSign in for TTM
EBITDA154 Cr186 Cr243 CrSign in for TTM
OPM %14.3%15.0%14.9%Sign in for TTM
Other income12 Cr12 Cr7 CrSign in for TTM
Interest21 Cr2 Cr17 CrSign in for TTM
Depreciation16 Cr25 Cr45 CrSign in for TTM
Profit before tax130 Cr171 Cr188 CrSign in for TTM
Tax %27.2%25.0%25.1%Sign in for TTM
Net profit94 Cr128 Cr141 CrSign in for TTM
EPS (₹)₹18.66₹22.41₹24.63Sign in for TTM
Dividend payout %0.0%0.0%8.1%Sign in for TTM
Sign in for TTM

Trailing twelve months totals and margin rows

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2024Mar 2025Mar 2026
Equity capital57 Cr57 Cr57 Cr
Reserves774 Cr902 Cr1,034 Cr
Borrowings245 Cr338 Cr344 Cr
Other liabilities245 Cr283 Cr403 Cr
Total liabilities1,321 Cr1,580 Cr1,837 Cr
Fixed assets (net)340 Cr812 Cr823 Cr
CWIP341 Cr23 Cr16 Cr
Investments0 Cr0 Cr41 Cr
Loans & advances0.44 Cr0.68 Cr0.44 Cr
Inventories144 Cr208 Cr283 Cr
Trade receivables288 Cr332 Cr437 Cr
Cash & bank12 Cr16 Cr3 Cr
Other assets195 Cr190 Cr233 Cr
Total assets1,321 Cr1,580 Cr1,837 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2024Mar 2025Mar 2026
Cash from operating activity146 Cr64 Cr117 Cr
Cash from investing-499 Cr-152 Cr-107 Cr
Cash from financing361 Cr92 Cr-22 Cr
Net cash flow8 Cr4 Cr-12 Cr
Free cash flow (OCF − Capex)-141 Cr-109 Cr48 Cr

Ratios

Ratios as reported or derived per annual period.

MetricMar 2024Mar 2025Mar 2026
ROCE %14.0%13.4%14.3%
ROE %0.0%0.0%0.0%
Debtor days979798
Inventory days7695103
Days payable9492115
Cash conversion cycle7910085
Debt / equity0.290.350.32
Current ratio2.181.971.87
Net debt / EBITDA1.511.731.40

Compare with peers

Loading peers…